Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
AusPAR: Ezetimibe / Rosuvastatin (as calcium)
Australian Public Assessment Report
Device/Product Name
Rosuzet, Ezalo
Active ingredients
Ezetimibe / Rosuvastatin (as calcium)
AusPAR Date
Published
Submission Number
PM-2013-02434-1-3
Submission Type
New fixed dose combination
Decision
Approved